Company Profile
Shenzhen Efung Capital is one of the earliest venture capital institutions that specialized in biomedicine investment in China. Efung has a high-caliber management team and an experienced investment team, which consist of MDs/PhDs graduated from professional institutions at home and abroad. It focuses on medical and healthcare sectors, especially in VC and PE investment in biopharmaceuticals and high-end medical devices. Throughout these years, Efung has explored profoundly the potentials of healthcare industry, and has invested over 50 prominent companies globally, such as Chipscreen Bioscience, Frontier Biotech, Ascentage Pharma, Lifotronic Technology, Apexigen and Centrexion et al. Efung Capital has demonstrated a solid track record, and has achieved strong revenue and earnings growth. It was recognized as “Zero2IPO Group2020 Best Healthcare Investment Institution TOP30”, “ChinaVenture 2019 Best Exit Cases TOP10”and “The Most Dynamic Pharmaceutical VC Institutions in China”. It has also been elected as “Shenzhen TOP10 VC Institutions” for several consecutive years, and once was theme covered by Nature magazine.
                Development Path                               
<
  • 2001
    2001
    The founder of Efung Captital invested Mindray Medical
  • 2007
    2007
    Efung Captital was officially established and had formed a professional investment team.
  • 2012
    2012
    Transformed into a life-science focused venture capital firm.
  • 2014
    2014
    Raised and invested the first fund.
  • 2015
    2015
    Started the research and analysis of oversea pharmaceutical and healthcare industry.
  • 2017
    2017
    Start laying out overseas high-quality projects
  • 2019
    2019
    The invested projects are listed one after another
  • 2021
    2021
    Efung JunMa was established
>
Advantages
——
——
Professional
——
——
Focused
——
——
Resourceful
——
——
Strategic
——
——
Collaborative
——
——
Prudent
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务
进入手机网站